World's Best Scientists 2026 revealed!
Massimo Massaia

Massimo Massaia

D-Index & Metrics

Biology and Biochemistry

D-Index
51
Citations
8663
World Ranking
17240
National Ranking
547

Overview

Massimo Massaia is affiliated with the University of Turin in Italy, contributing extensively to the field of medicine with a focus on oncology, genetics, pathology and forensic medicine, hematology, and immunology. Their research output includes 121 publications primarily centered on these medical disciplines.

Their work frequently appears in several notable scientific journals, including Blood with 10 publications, British Journal of Haematology with 6, Hematological Oncology with 4, Frontiers in Immunology with 3, and Haematologica also with 3. These venues reflect a strong emphasis on hematology and oncology research.

Massaia's most cited papers demonstrate a focus on COVID-19 in patients with hematological malignancies and on immune responses in blood cancers. Selected recent papers include:

  • Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study, 2020, The Lancet Haematology
  • COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies, 2021, British Journal of Haematology
  • A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study, 2021, Blood Advances
  • The immune suppressive tumor microenvironment in multiple myeloma: The contribution of myeloid-derived suppressor cells, 2023, Frontiers in Immunology
  • Molecular dynamics of targeting CD38 in multiple myeloma, 2021, British Journal of Haematology

The main topics of Massaia's research include chronic lymphocytic leukemia research, lymphoma diagnosis and treatment, CAR-T cell therapy research, multiple myeloma research and treatments, as well as COVID-19 related healthcare impacts and clinical research studies. This diverse range of topics highlights an engagement with both cancer immunology and infectious disease intersections.

  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Multiple Myeloma Research and Treatments
  • COVID-19 and healthcare impacts
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research

Frequent collaborators in Massaia's research include Paolo Corradini, Luca Arcaini, Mauro Krampera, Sara Galimberti, and Maria Chiara Tisi. These co-authors reflect a collaborative network primarily focused on hematology and oncology research in Italian and international contexts.

  • Paolo Corradini
  • Luca Arcaini
  • Mauro Krampera
  • Sara Galimberti
  • Maria Chiara Tisi

Massimo Massaia's scientific contributions are situated at the intersection of clinical hematology, oncology, and immunology, with a consistent focus on blood cancers and the implications of infectious diseases such as COVID-19 in immunocompromised patients. Their ongoing research presence within prominent scientific venues underscores a sustained engagement with advancing knowledge in these medical fields.

Best Publications

  • A comparison of allografting with autografting for newly diagnosed myeloma.

    Benedetto Bruno;Marcello Rotta;Francesca Patriarca;Nicola Mordini

  • Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.

    Francesco Passamonti;Chiara Cattaneo;Luca Arcaini;Riccardo Bruna

  • Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells.

    Antonio Curti;Simona Pandolfi;Barbara Valzasina;Michela Aluigi

  • CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib.

    Roberto Piva;Roberto Piva;Bruce Ruggeri;Michael Williams;Giulia Costa

  • Zoledronic acid repolarizes tumour‐associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway

    Marta Coscia;Elena Quaglino;Manuela Iezzi;Claudia Curcio

  • Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia.

    Davide Rossi;Lodovico Terzi-di-Bergamo;Lorenzo De Paoli;Michaela Cerri

  • Production of Tumor Necrosis Factor-alpha by B-Cell Chronic Lymphocytic Leukemia Cells: A Possible Regulatory Role of TNF in the Progression of the Disease

    R Foa;M Massaia;S Cardona;AG Tos

  • Idiotype Vaccination in Human Myeloma: Generation of Tumor-Specific Immune Responses After High-Dose Chemotherapy

    Massimo Massaia;Paolo Borrione;Paolo Borrione;Silvano Battaglio;Silvano Battaglio;Sara Mariani;Sara Mariani

  • Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancy

    Vincenzo Squadrone;Massimo Massaia;Benedetto Bruno;Filippo Marmont

  • Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5'-nucleotidase (CD73).

    L. F. Thomson;J. M. Ruedi;A. Glass;G. Moldenhauer

  • Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma.

    Sara Mariani;M Muraro;F Pantaleoni;F Fiore

  • Chlorambucil plus rituximab with or without maintenance rituximab as first‐line treatment for elderly chronic lymphocytic leukemia patients

    Robin Foà;Ilaria Del Giudice;Antonio Cuneo;Giovanni Del Poeta

  • Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase.

    A Curti;M Aluigi;S Pandolfi;E Ferri

  • Antitumor vaccination: where we stand

    M. Bocchia;V. Bronte;M. P. Colombo;A. De Vincentiis

  • Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia.

    D Rossi;C Lobetti Bodoni;E Genuardi;L Monitillo

  • Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid.

    Francesca Fiore;Barbara Castella;Barbara Nuschak;Raffaello Bertieri

  • Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO).

    Giovanni Barosi;Mario Boccadoro;Michele Cavo;Paolo Corradini

  • Distribution of terminal deoxynucleotidyl transferase and purine degradative and synthetic enzymes in subpopulations of human thymocytes.

    D. D. F. Ma;T. A. Sylwestrowicz;S. Granger;M. Massaia

  • Anti-CD38 Antibody Therapy: Windows of Opportunity Yielded by the Functional Characteristics of the Target Molecule

    Antonella Chillemi;Gianluca Zaccarello;Valeria Quarona;Manuela Ferracin

  • Early responder myeloma: kinetic studies identify a patient subgroup characterized by very poor prognosis.

    M Boccadoro;F Marmont;M Tribalto;G Fossati

Frequent Co-Authors

Mario Boccadoro
Mario Boccadoro University of Turin
Chiara Riganti
Chiara Riganti University of Turin
Antonio Palumbo
Antonio Palumbo University of Turin
Umberto Dianzani
Umberto Dianzani University of Eastern Piedmont Amadeo Avogadro
Gianluca Gaidano
Gianluca Gaidano University of Eastern Piedmont Amadeo Avogadro
Davide Rossi
Davide Rossi European Society for Medical Oncology
Robin Foà
Robin Foà Sapienza University of Rome
Massimo Aglietta
Massimo Aglietta University of Turin
Paolo Corradini
Paolo Corradini University of Milan
Amalia Bosia
Amalia Bosia University of Turin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA opens doors to a range of online degrees and flexible professional pathways. For those interested in healthcare, earning an online asn program can be a valuable step toward nursing careers, combining foundational science with hands-on learning.

Nutrition is closely linked to biochemistry, and pursuing online nutrition degrees allows students to specialize in dietetics or health coaching. These programs cater to individuals aiming to impact public health and wellness.

For those aspiring to leadership roles in healthcare organizations, top cahme-accredited mha programs provide a strong foundation in healthcare administration, policy, and management.

Additionally, nurses seeking advanced practice or leadership positions can consider msn to dnp online no clinicals programs, which offer a streamlined path to the Doctor of Nursing Practice without traditional clinical requirements.

With the flexibility of online education, students can tailor their academic experience to fit their career goals in science, healthcare, and administration.

Best Scientists Citing Massimo Massaia

Trending Scientists